Nu Skin Enterprises, Inc. (NUS) stock
NUSNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 12/3068% below fair value
$4.03+0.02 (+0.50%)
Close on Nov 13, 2026Market cap $196.17MP/E –Yield –
Nu Skin Enterprises cash
Cash and short-term investments held at the end of each period.
Nu Skin Enterprises's cash was $166.64M at Sep 30, 2026. For fiscal 2025 it was $239.84M, up 21.1% from the year before. Over ten years it grew -2.3% a year on average. The highest annual figure on record is $547.13M in fiscal 2013.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $239.84M | +21.1% |
| FY2024 | Dec 31, 2024 | $197.99M | -26.1% |
| FY2023 | Dec 31, 2023 | $267.82M | -3.8% |
| FY2022 | Dec 31, 2022 | $278.51M | -21.5% |
| FY2021 | Dec 31, 2021 | $354.81M | -16.3% |
| FY2020 | Dec 31, 2020 | $423.90M | +23.2% |
| FY2019 | Dec 31, 2019 | $344.04M | -13.6% |
| FY2018 | Dec 31, 2018 | $398.26M | -9.1% |
| FY2017 | Dec 31, 2017 | $438.25M | +19.0% |
| FY2016 | Dec 31, 2016 | $368.13M | +21.2% |
| FY2015 | Dec 31, 2015 | $303.73M | +1.2% |
| FY2014 | Dec 31, 2014 | $300.21M | -45.1% |
| FY2013 | Dec 31, 2013 | $547.13M | +64.1% |
| FY2012 | Dec 31, 2012 | $333.40M | +14.7% |
| FY2011 | Dec 31, 2011 | $290.70M | +26.2% |
| FY2010 | Dec 31, 2010 | $230.34M | +45.7% |
| FY2009 | Dec 31, 2009 | $158.05M | +37.9% |
| FY2008 | Dec 31, 2008 | $114.59M | +31.2% |
| FY2007 | Dec 31, 2007 | $87.33M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $166.64M | -34.1% |
| Q2 FY2026 | Jun 30, 2026 | $191.39M | -27.9% |
| Q1 FY2026 | Mar 31, 2026 | $200.41M | -6.2% |
| Q4 FY2025 | Dec 31, 2025 | $239.84M | +21.1% |
| Q3 FY2025 | Sep 30, 2025 | $253.00M | +6.4% |
| Q2 FY2025 | Jun 30, 2025 | $265.37M | +13.9% |
| Q1 FY2025 | Mar 31, 2025 | $213.55M | -3.5% |
| Q4 FY2024 | Dec 31, 2024 | $197.99M | -26.1% |
| Q3 FY2024 | Sep 30, 2024 | $237.83M | -4.9% |
| Q2 FY2024 | Jun 30, 2024 | $232.92M | -7.7% |
| Q1 FY2024 | Mar 31, 2024 | $221.21M | -10.3% |
| Q4 FY2023 | Dec 31, 2023 | $267.82M | -3.8% |
| Q3 FY2023 | Sep 30, 2023 | $249.99M | -18.8% |
| Q2 FY2023 | Jun 30, 2023 | $252.33M | -33.9% |
| Q1 FY2023 | Mar 31, 2023 | $246.72M | -22.3% |
| Q4 FY2022 | Dec 31, 2022 | $278.51M | -21.5% |
| Q3 FY2022 | Sep 30, 2022 | $308.00M | +2.1% |
| Q2 FY2022 | Jun 30, 2022 | $381.80M | +0.7% |
| Q1 FY2022 | Mar 31, 2022 | $317.53M | -12.5% |
| Q4 FY2021 | Dec 31, 2021 | $354.81M | -16.3% |
| Q3 FY2021 | Sep 30, 2021 | $301.60M | -20.2% |
| Q2 FY2021 | Jun 30, 2021 | $379.26M | -1.8% |
| Q1 FY2021 | Mar 31, 2021 | $362.71M | +0.3% |
| Q4 FY2020 | Dec 31, 2020 | $423.90M | +23.2% |
| Q3 FY2020 | Sep 30, 2020 | $378.01M | +15.4% |
| Q2 FY2020 | Jun 30, 2020 | $386.30M | +4.9% |
| Q1 FY2020 | Mar 31, 2020 | $361.67M | +13.6% |
| Q4 FY2019 | Dec 31, 2019 | $344.04M | -13.6% |
| Q3 FY2019 | Sep 30, 2019 | $327.49M | -18.4% |
| Q2 FY2019 | Jun 30, 2019 | $368.37M | -10.2% |
| Q1 FY2019 | Mar 31, 2019 | $318.33M | -26.0% |
| Q4 FY2018 | Dec 31, 2018 | $398.26M | -9.1% |
| Q3 FY2018 | Sep 30, 2018 | $401.45M | +8.0% |
| Q2 FY2018 | Jun 30, 2018 | $410.23M | +16.2% |
| Q1 FY2018 | Mar 31, 2018 | $430.10M | +23.8% |
| Q4 FY2017 | Dec 31, 2017 | $438.25M | +19.0% |
| Q3 FY2017 | Sep 30, 2017 | $371.75M | – |
| Q2 FY2017 | Jun 30, 2017 | $353.08M | – |
| Q1 FY2017 | Mar 31, 2017 | $347.34M | – |
| Q4 FY2016 | Dec 31, 2016 | $368.13M | – |
See a number that looks wrong?